Country Profile

Cambodia

Cambodia is a growing market for Indian pharmaceuticals — $69.2M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $6.79M. The compound annual growth rate since FY2015 stands at 5.9%.

🇰🇭 $69.2M · 1.9× growth since FY2015 · 5.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$69.2M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
5.9%
CAGR FY2015→2026
85%
Medicines Share
5
Product Categories Supplied
Cambodia is a growing market for Indian pharmaceuticals — $69.2M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 85% of shipments, with vaccines contributing $6.79M. The compound annual growth rate since FY2015 stands at 5.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $58.5M (84.6%) Vaccines $6.79M (9.8%) Medicine Ingredients $3.09M (4.5%) Traditional & Herbal $399K (0.6%) Surgical & Hospital Supplies $354K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Cambodia in the RBI overseas direct investment dataset (2011–2026).